The Relationship Between the Type of bcr-abl Hybrid Messenger RNA and Thrombopoiesis in Philadelphia-Positive Chronic Myelogenous Leukemia

References

• Failkow P. J., Jacobson R. J., Papayannopoulu T. Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet, and monocyte/macrophage. Am. J. Med 1977; 63: 125–130
   PubMed Web of Science ®Google Scholar
• Nowell P. C., Hungerford D. A. A minute chromosome in human chronic granulocytic leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Rowley J. D. A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Gicmsa staining. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Riddle M. C., Sturgis C. C. Basal metabolism in chronic myelogenous leukemia. Arch. Intern. Med. 1927; 39: 255–274
   Google Scholar
• Bernards A., Rubin C. M., Westbrook C. A., Pasking M., Baltimore D. The first intron in the human c-abl gene is at least 200 kilobases long and is the target for translocations in chronic myelogenous leukemia. Mol. Cell Biol 1987; 7: 3231–3236
   PubMed Web of Science ®Google Scholar
• Groffen J., Stephenson J. R., Heisterkamp N., del Klein A., Bartram C. R., Grosveld G. Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22. Cell 1984; 36: 93–99
   PubMed Web of Science ®Google Scholar
• Heisterkamp N., Stam K., Groffen J., deKlein A., Grosveld G. Structural organization of the bcr gene and its role in the Ph1 translocation. Nature 1984; 315: 758–761
   Web of Science ®Google Scholar
• Ben Neriah Y., Daley G. Q., Mes-Masson A. M., Witte O. N., Baltimore D. The chronic myelogenous leukemia-specific P210 protein is Ihe product of the bcr/abl hybrid gene. Science 1986; 233: 212–214
   PubMed Web of Science ®Google Scholar
• Roth M. S., Antin J. H., Bingham E. L., Ginsburg D. Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia. Blood 1989; 74: 882–885
   PubMed Web of Science ®Google Scholar
• Morgan G. J., Hernandez A., Chan L. G., Hughes T., Martiat P., Wiedemann L. M. The role of alternative splicing patterns of BCR/ABL transcripts in the generation of the blast crisis of chronic myeloid leukemia. Br. J. Haematoi 1990; 76: 33–38
   PubMed Web of Science ®Google Scholar
• Schaefer-Rego K., Dudek H., Popenoe D., Artin Z., Mears J. G., Bank A., Leibowitz D. CML patients in blast crisis have breakpoints localized to a specific region of the BCR. Blood 1987; 70: 448–455
   PubMed Web of Science ®Google Scholar
• Inokuchi K., Futaki M., Yamada T., Tanabe Y., Dan K., Shinohara T., Kuriya S., Nomura T. The relationship between the site of breakpoints within the BCR gene and thrombopoiesis of Philadelphia-positive chronic myelocytic leukemia. Leukem. Res. 1991; 15: 1067–1073
   PubMed Web of Science ®Google Scholar
• Inokuchi K., Inoue T., Tojo A., Futaki M., Miyake K., Yamada T., Tanabe Y., Ohki I., Dan K., Ozawa K., Asano S., Nomura T. A possible correlation between the type of bcr-abl hybrid messenger RNA and platelet count in Philadelphia-positive chronic myelogenous leukemia. Blood 1991; 78: 3125–3127
   PubMed Web of Science ®Google Scholar
• Hirosawa S., Aoki N., Matsushima H., Shibuya M. Undetectable bcr-abl rearrangements in some CML patients are due to a deletion mutation in the bcr gene. Am. J. Hemat. 1988; 28: 33–36
   PubMed Web of Science ®Google Scholar
• Vainchenker W., Bouguet J., Guichard J., Breton-Gorius J. Megakaryocyte colony formation from human bone marrow precursors. Blood 1979; 54: 940–945
   PubMed Web of Science ®Google Scholar
• Ogata K., Kuriya S., Dan K., Nomura T. Partial purification of human urinary megakaryocyte colony-stimulating factor. Expl. Cell. Biol 1989; 57: 19–26
   PubMedGoogle Scholar
• Chirgwin J. M., Przybyla A. E., MacDonald R. J., Rutter W. J. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 1979; 18: 5294–5299
   PubMed Web of Science ®Google Scholar
• Kawasaki E. S., Clark S. S., Coyne M. Y., Smith S. D., Champlin R., Witte O. N., McCormick F. P. Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro. Proc. Natl. Acad. Sci. U.S.A. 1988; 85: 5698–5702
   PubMed Web of Science ®Google Scholar
• Futaki M., Inokuchi K., Dan K., Nomura T. Activation of bcr-abl fusion gene and ras oncogenes in chronic myelogenous leukemia. Leukem Lymphom. 1991; 5: 163–169
   PubMed Web of Science ®Google Scholar
• Mills K. I., MacKenzie E. D., Birnie G. D. The site of the breakpoint within the bcr is a prognostic factor in Philadelphia positive CML patients. Blood 1988; 11: 1237–1241
   Google Scholar
• Shtalrid M., Talpaz M., Kurzrock R., Kantarjian H., Trujillo J., Gutterman J., Gaiina Y., Mark B. Analysis of breakpoints within the bcr gene and their correlation with clinical course of Philadelphia positive chronic myelogenous leukemia. Blood 1988; 72: 485–490
   PubMed Web of Science ®Google Scholar
• Jaubert J., Martiat P., Dowding C., Ifrah N., Goldman J. W. The position on the M-BCR breakpoint does not predict the duration of chronic phase or survival in chronic myeloid leukemia. Br. J. Haematol 1990; 74: 30–35
   PubMed Web of Science ®Google Scholar
• Morris S. W., Daniel L., Ahmed C. M. I., Elias A., Lebowitz P. Relationship of bcr breakpoint to chronic phase duration, survival, and blast crisis lineage in chronic myelogenous leukemia patients presenting in early chronic phase. Blood 1990; 75: 2035–2041
   PubMed Web of Science ®Google Scholar
• Grossman A., Silver R. T., Arlin Z., Coleman M., Camposano E., Gascon P., Benn P. A. Fine mapping of chromosome 22 breakpoints within the breakpoint cluster region (bcr) implies a role for bcr exon 3 in determining disease duration in chronic myeloid leukemia. Am. J. Hum. Genet. 1989; 45: 729–738
   PubMed Web of Science ®Google Scholar
• Tien H. F., Wang C. H., Chen Y. C., Shen M. C., Wu H. S., Lee F. Y., Chauang S. M., Liu C. H. Chromosome and bcr rearrangement in chronic myelogenous leukemia and their correlation with clinical states and prognosis of the disease. Br. J. Haematol 1990; 75: 469–475
   PubMed Web of Science ®Google Scholar
• Tefferi A., Bren G. D., Wagner K. V., Schaid D. J., Ash R. C., Thinbodeau S. N. The location of the Philadelphia chromosomal breakpoint site and prognosis in chronic granulocytic leukemia. Leukemia 1990; 4: 839–842
   PubMed Web of Science ®Google Scholar
• Shepherd P. C. A., Bond C., Allan N. C. Molecular breakpoints and platelet counts in chronic myeloid leukemia. Inokuchi, K., Futaki, M., Miyake, K., Yamada, T., Tanabe, Y., Ohki, I., Dan, K., Nomura, T., Inoue, T., Tojo, A., Ozawa, K. and Asano, S.: Response. Blood 1992; 80: 556–557
   PubMed Web of Science ®Google Scholar
• Mason J. H., Devita V. T., Jr., Canellos G. P. Thrombocytosis in chronic granulocytic leukemia: Incidence and clinical significance. Blood 1974; 44: 483–487
   PubMed Web of Science ®Google Scholar
• Martiat P., Ifrah N., Rassool F., Morgan G., Giles F., Gow J., Goldman J. M. Molecular analysis of Philadelphia positive essential thrombocythemia. Leukemia 1989; 3: 563–567
   PubMed Web of Science ®Google Scholar
• Morris C. M., Heisterkamp N., Groffen J., Fitzgerald P. H. Entire ABL gene is joined with 5-BCR in some patients with Philadelphia-positive leukemia. Blood 1991; 1078–1084
   PubMed Web of Science ®Google Scholar